Essa Pharma is facing a call to wind down operations. Soleus Capital Management, one of the company’s largest shareholders, put the proposal to Essa’s board of directors after concluding that the best ...

Essa Pharma’s sole clinical-stage candidate was on track to fall short against Xtandi in a phase 2 prostate cancer trial, leading the biotech to terminate the study, abandon the candidate and “review ...

ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX), a pharmaceutical company that, prior to the discontinuation of its clinical trials and development programs, had been focused on developing ...

ESSA Pharma (NASDAQ:EPIX) plummeted about 70% premarket on Friday after ending its Phase 2 trial for a prostate cancer treatment. The trial tested masofaniten with enzalutamide versus enzalutamide ...

STROUDSBURG, PA--(Marketwired - Dec 4, 2015) - ESSA Bancorp, Inc. ("ESSA Bancorp") (NASDAQ: ESSA) today announced that its acquisition of Eagle National Bancorp, Inc. ("ENB") and its wholly owned ...

The most recent version of the Elementary and Secondary Education Act, called the Every Student Succeeds Act (ESSA), included in its design an attempt to scale back some of the burdensome federal ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Essa Bancorp ( (ESSA)) just unveiled ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...